2023 Q2 Form 10-Q Financial Statement
#000121390023038233 Filed on May 11, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|
Revenue | $71.00K | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $9.080M | $3.833M | $3.120M |
YoY Change | 301.41% | 114.49% | 24.65% |
% of Gross Profit | |||
Research & Development | $2.000K | $0.00 | $30.00K |
YoY Change | -94.44% | -100.0% | -63.41% |
% of Gross Profit | |||
Depreciation & Amortization | $20.00K | $7.000K | |
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $9.082M | $3.834M | $3.140M |
YoY Change | 295.21% | 0.82% | 21.47% |
Operating Profit | -$9.011M | -$3.834M | |
YoY Change | 292.12% | 0.82% | |
Interest Expense | $560.0K | $70.00K | -$4.110M |
YoY Change | -120.15% | -65.69% | -630.32% |
% of Operating Profit | |||
Other Income/Expense, Net | $348.0K | $72.00K | $0.00 |
YoY Change | -112.52% | 12.5% | |
Pretax Income | -$8.660M | -$3.760M | -$7.260M |
YoY Change | 70.57% | 6.36% | 301.1% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$8.663M | -$3.762M | -$7.260M |
YoY Change | 70.63% | 6.42% | 301.1% |
Net Earnings / Revenue | -12201.41% | ||
Basic Earnings Per Share | -$1.79 | -$0.71 | |
Diluted Earnings Per Share | -$1.79 | -$0.71 | -$1.32 |
COMMON SHARES | |||
Basic Shares Outstanding | 4.593M shares | 4.841M shares | 5.485M shares |
Diluted Shares Outstanding | 4.827M shares | 5.306M shares |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $24.27M | $33.93M | $40.30M |
YoY Change | -40.18% | -50.52% | -51.71% |
Cash & Equivalents | $3.598M | $9.533M | $33.17M |
Short-Term Investments | $20.68M | $24.39M | $7.130M |
Other Short-Term Assets | $7.800M | $4.300M | $900.0K |
YoY Change | 3879.59% | -79.81% | 103.62% |
Inventory | |||
Prepaid Expenses | $301.0K | ||
Receivables | $6.300M | $6.500M | $7.500M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $38.42M | $44.77M | $50.66M |
YoY Change | -37.59% | -54.86% | -44.27% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $387.0K | $353.0K | |
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $23.20M | $23.10M | $23.10M |
YoY Change | -8.94% | 24.13% | 144.06% |
Other Assets | $500.0K | $500.0K | $500.0K |
YoY Change | 222.58% | 222.58% | 222.58% |
Total Long-Term Assets | $29.27M | $29.38M | $25.58M |
YoY Change | 9.5% | 56.58% | 117.39% |
TOTAL ASSETS | |||
Total Short-Term Assets | $38.42M | $44.77M | $50.66M |
Total Long-Term Assets | $29.27M | $29.38M | $25.58M |
Total Assets | $67.70M | $74.15M | $76.24M |
YoY Change | -23.33% | -37.13% | -25.74% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $200.0K | $600.0K | $400.0K |
YoY Change | 40.85% | 187.08% | 4.99% |
Accrued Expenses | $1.000M | $1.000M | $1.300M |
YoY Change | 45.56% | 45.77% | 91.18% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.658M | $1.720M | $1.789M |
YoY Change | 220.63% | 92.18% | 68.61% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $3.300M | $3.400M | $700.0K |
YoY Change | |||
Total Long-Term Liabilities | $3.300M | $3.400M | $700.0K |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.658M | $1.720M | $1.789M |
Total Long-Term Liabilities | $3.300M | $3.400M | $700.0K |
Total Liabilities | $5.917M | $5.083M | $2.469M |
YoY Change | 613.75% | 467.93% | 132.7% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$198.3M | -$189.6M | -$185.9M |
YoY Change | 15.04% | 13.5% | |
Common Stock | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $501.0K | $501.0K | $3.322M |
YoY Change | -71.37% | 1158.33% | |
Treasury Stock Shares | |||
Shareholders Equity | $61.78M | $69.07M | $73.77M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $67.70M | $74.15M | $76.24M |
YoY Change | -23.33% | -37.13% | -25.74% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$8.663M | -$3.762M | -$7.260M |
YoY Change | 70.63% | 6.42% | 301.1% |
Depreciation, Depletion And Amortization | $20.00K | $7.000K | |
YoY Change | |||
Cash From Operating Activities | -$9.920M | -$3.991M | -$1.860M |
YoY Change | 387.23% | 4.04% | -9.18% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $60.00K | $360.0K | $1.300M |
YoY Change | -6600.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $4.040M | -$18.35M | $2.660M |
YoY Change | -177.69% | 82.08% | -95.67% |
Cash From Investing Activities | $3.990M | -$18.71M | $1.360M |
YoY Change | -176.73% | 85.66% | -97.79% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | -$939.0K | -820.0K |
YoY Change | -100.0% | -104.94% | -456.52% |
NET CHANGE | |||
Cash From Operating Activities | -9.920M | -$3.991M | -1.860M |
Cash From Investing Activities | 3.990M | -$18.71M | 1.360M |
Cash From Financing Activities | 0.000 | -$939.0K | -820.0K |
Net Change In Cash | -5.930M | -$23.64M | -1.320M |
YoY Change | -81.38% | -565.65% | -102.21% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$9.920M | -$3.991M | -$1.860M |
Capital Expenditures | $60.00K | $360.0K | $1.300M |
Free Cash Flow | -$9.980M | -$4.351M | -$3.160M |
YoY Change | 390.18% | 13.43% | 55.82% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5252517 | shares |
CY2022Q4 | us-gaap |
Alternative Investment
AlternativeInvestment
|
23103000 | usd |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
000-05576 | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
domh |
Lower Valuation
LowerValuation
|
48.16 | ||
CY2022Q4 | us-gaap |
Stock Dividends Shares
StockDividendsShares
|
600000 | shares |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
52-0849320 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
725 5th Avenue | |
CY2023Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
22nd Floor, | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10022 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
(703) | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
992-9325 | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q1 | dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value | |
CY2023Q1 | dei |
Trading Symbol
TradingSymbol
|
DOMH | |
CY2023Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4592578 | shares |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9533000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
33174000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
24394000 | usd |
CY2022Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
7130000 | usd |
CY2023Q1 | domh |
Clearing Broker Deposits
ClearingBrokerDeposits
|
3550000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
745000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
564000 | usd |
CY2022Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
301000 | usd |
CY2023Q1 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
13000 | usd |
CY2022Q4 | us-gaap |
Other Short Term Investments
OtherShortTermInvestments
|
13000 | usd |
CY2023Q1 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
6536000 | usd |
CY2022Q4 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
7474000 | usd |
CY2022Q4 | domh |
Investment In Field Point Securitie
InvestmentInFieldPointSecuritie
|
2000000 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
44771000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
50656000 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
353000 | usd |
CY2023Q1 | us-gaap |
Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
|
1850000 | usd |
CY2022Q4 | us-gaap |
Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
|
1100000 | usd |
CY2023Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
23103000 | usd |
CY2022Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
23103000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
3619000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
919000 | usd |
CY2023Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
458000 | usd |
CY2022Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
458000 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
74154000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
76236000 | usd |
CY2023Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
641000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
447000 | usd |
CY2023Q1 | domh |
Accrued Salaries And Benefit
AccruedSalariesAndBenefit
|
732000 | usd |
CY2022Q4 | domh |
Accrued Salaries And Benefit
AccruedSalariesAndBenefit
|
1260000 | usd |
CY2023Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
25000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
198000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
82000 | usd |
CY2023Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
124000 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1720000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1789000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
3363000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
680000 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
5083000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
2469000 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4815597 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5485096 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4755449 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5017079 | shares |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
259215000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
262970000 | usd |
CY2023Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
60148 | shares |
CY2022Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
468017 | shares |
CY2023Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
501000 | usd |
CY2022Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
3322000 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-189643000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-185881000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
69071000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
73767000 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
74154000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
76236000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3833000 | usd |
CY2022Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1787000 | usd |
CY2023Q1 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
1000 | usd |
CY2022Q1 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
2016000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3834000 | usd |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3803000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3834000 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3803000 | usd |
CY2022Q1 | us-gaap |
Other Income
OtherIncome
|
64000 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
137000 | usd |
CY2022Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
179000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
-65000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
-497000 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
522000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
72000 | usd |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
268000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3762000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3535000 | usd |
CY2022Q1 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
3009000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-3762000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-6544000 | usd |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.71 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.25 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5305513 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5252517 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
73767000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
|
5000 | usd |
CY2023Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
939000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3762000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
69071000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
101595000 | usd |
CY2022Q1 | domh |
Redemption Of Series P Redeemable Convertible Preferred Stock
RedemptionOfSeriesPRedeemableConvertiblePreferredStock
|
-3009000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3535000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
95051000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3762000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3535000 | usd |
CY2023Q1 | domh |
Amortization Of Rightofuse Assets
AmortizationOfRightofuseAssets
|
-92000 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
7000 | usd |
CY2022Q1 | domh |
Change In Fair Value Of Shortterm Investment
ChangeInFairValueOfShorttermInvestment
|
886000 | usd |
CY2022Q1 | domh |
Change In Fair Value Of Longterm Investment
ChangeInFairValueOfLongtermInvestment
|
-1408000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-56000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-224000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-130000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-333000 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
64000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
221000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-66000 | usd |
CY2023Q1 | domh |
Increase Decrease In Prepaid Acquisition Cost
IncreaseDecreaseInPrepaidAcquisitionCost
|
-301000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-19000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-172000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
-528000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
6000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
7000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
3000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
|
62000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
|
179000 | usd |
CY2022Q1 | domh |
Amortization Of Rightofuse Assets
AmortizationOfRightofuseAssets
|
usd | |
CY2022Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-7000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3991000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3836000 | usd |
CY2023Q1 | domh |
Purchase Of Marketable Securities
PurchaseOfMarketableSecurities
|
17519000 | usd |
CY2022Q1 | domh |
Purchase Of Marketable Securities
PurchaseOfMarketableSecurities
|
27096000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
68000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
24662000 | usd |
CY2022Q1 | domh |
Proceeds From Sale Of Dat Chat Common Shares
ProceedsFromSaleOfDatChatCommonShares
|
93000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
361000 | usd |
CY2023Q1 | domh |
Return Of Depositfunding Of Deposit Into A Managed Account Net
ReturnOfDepositfundingOfDepositIntoAManagedAccountNet
|
1149000 | usd |
CY2023Q1 | domh |
Purchase Of Convertible Note
PurchaseOfConvertibleNote
|
-250000 | usd |
CY2022Q1 | domh |
Purchase Of Shortterm And Longterm Promissory Notes
PurchaseOfShorttermAndLongtermPromissoryNotes
|
7737000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-18711000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10078000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
18991000 | usd |
CY2023Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
939000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-939000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
18991000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-23641000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
5077000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
33174000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
65562000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9533000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
70639000 | usd |
CY2022Q1 | domh |
Transfer From Longterm Investment To Marketable Securites
TransferFromLongtermInvestmentToMarketableSecurites
|
1482000 | usd |
CY2022Q1 | domh |
Promissory Convertible Note Receivable Conversion Into Common Shares
PromissoryConvertibleNoteReceivableConversionIntoCommonShares
|
2147000 | usd |
CY2023Q1 | us-gaap |
Stock Issued1
StockIssued1
|
3149000 | usd |
CY2023Q1 | domh |
Less Deposit Previously Transferred In October2022 To Fps
LessDepositPreviouslyTransferredInOctober2022ToFPS
|
2000000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1149000 | usd |
CY2023Q1 | domh |
Reverse Stock Split
ReverseStockSplit
|
30000.00 | usd |
CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q1 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
3400000 | usd |
CY2023Q1 | us-gaap |
Deposits
Deposits
|
100000 | usd |
CY2021Q3 | domh |
Interest
Interest
|
1000000 | usd |
CY2023Q1 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
3400000 | usd |
CY2023Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
92000 | usd |
CY2023Q1 | domh |
Deposits With Clearing Broker Dealer
DepositsWithClearingBrokerDealer
|
3550000 | usd |
CY2023Q1 | us-gaap |
Other Receivables
OtherReceivables
|
53000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
89000 | usd |
CY2023Q1 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
3784000 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
273000 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
|
25000 | usd |
CY2023Q1 | domh |
Wealth Management Liabilities
WealthManagementLiabilities
|
62000 | usd |
CY2023Q1 | us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
360000 | usd |
CY2023Q1 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
3424000 | usd |
CY2023Q1 | domh |
Net Loss
NetLoss
|
700000 | usd |
CY2023Q1 | us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
600000 | usd |
CY2023Q1 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
300000 | usd |
CY2023Q1 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
600000 | usd |
CY2023Q1 | domh |
Realizedloss Gain
RealizedlossGain
|
56000 | usd |
CY2022Q1 | domh |
Realizedloss Gain
RealizedlossGain
|
224000 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-130000 | usd |
CY2022Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-333000 | usd |
CY2023Q1 | us-gaap |
Dividend Income Operating
DividendIncomeOperating
|
119000 | usd |
CY2022Q1 | us-gaap |
Dividend Income Operating
DividendIncomeOperating
|
60000 | usd |
CY2023Q1 | domh |
Marketable Securities Gain Losses
MarketableSecuritiesGainLosses
|
-65000 | usd |
CY2022Q1 | domh |
Marketable Securities Gain Losses
MarketableSecuritiesGainLosses
|
-497000 | usd |
CY2023Q1 | us-gaap |
Alternative Investment
AlternativeInvestment
|
23103000 | usd |
CY2022Q4 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
1400000 | usd |
CY2022Q4 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
100000 | usd |
CY2021Q4 | us-gaap |
Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
|
250000 | shares |
CY2021Q4 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
1000000 | usd |
CY2021 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1000000 | usd |
CY2022Q2 | us-gaap |
Purchase Obligation
PurchaseObligation
|
2000000 | usd |
CY2022Q4 | domh |
Per Share
PerShare
|
0.5 | |
CY2022Q1 | us-gaap |
Payable Investment Purchase
PayableInvestmentPurchase
|
1500000 | usd |
CY2023Q1 | us-gaap |
Debt Instrument Fee Amount
DebtInstrumentFeeAmount
|
1800000 | usd |
CY2023Q1 | us-gaap |
Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
|
250000 | usd |
CY2023Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
40000.00 | usd |
CY2023Q1 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
0 | usd |
CY2023Q1 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
24394000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities
MarketableSecurities
|
24394000 | usd |
CY2023Q1 | domh |
Shortterm Investments
ShorttermInvestments
|
13000 | usd |
CY2023Q1 | domh |
Notes Receivable At Fair Value Current Portion
NotesReceivableAtFairValueCurrentPortion
|
6536000 | usd |
CY2023Q1 | domh |
Notes Receivable At Fair Value Noncurrent Portion
NotesReceivableAtFairValueNoncurrentPortion
|
1850000 | usd |
CY2022Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
7130000 | usd |
CY2022Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
7130000 | usd |
CY2022Q4 | domh |
Shortterm Investments
ShorttermInvestments
|
13000 | usd |
CY2022Q4 | domh |
Notes Receivable At Fair Value Current Portion
NotesReceivableAtFairValueCurrentPortion
|
7474000 | usd |
CY2022Q4 | domh |
Notes Receivable At Fair Value Noncurrent Portion
NotesReceivableAtFairValueNoncurrentPortion
|
1100000 | usd |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
13000 | usd |
CY2023Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
13000 | usd |
CY2022Q4 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
7474000 | usd |
CY2023Q1 | domh |
Collection Of Principal Outstanding
CollectionOfPrincipalOutstanding
|
-250000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
|
62000 | usd |
CY2023Q1 | domh |
Note Receivable Convergent Convertible Note Noncurrent Portion
NoteReceivableConvergentConvertibleNoteNoncurrentPortion
|
-750000 | usd |
CY2022Q1 | domh |
Share Buyback Program Amount
ShareBuybackProgramAmount
|
3000000 | usd |
CY2023Q1 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
6536000 | usd |
CY2022Q4 | domh |
Notes Receivableat Fair Value Non Current Portion
NotesReceivableatFairValueNon-CurrentPortion
|
1100000 | usd |
CY2023Q1 | us-gaap |
Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
|
750000 | usd |
CY2023Q1 | domh |
Notes Receivable At Fair Value Noncurrent Portion
NotesReceivableAtFairValueNoncurrentPortion
|
1850000 | usd |
CY2023Q1 | us-gaap |
Lessee Finance Lease Description
LesseeFinanceLeaseDescription
|
The initial term of the Company’s Lease is seven (7) years commencing on July 11, 2022 (“Commencement Date). | |
CY2023Q1 | us-gaap |
Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
|
12874 | usd |
CY2021Q4 | us-gaap |
Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
|
13502 | usd |
CY2022Q3 | us-gaap |
Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
|
49368 | usd |
CY2022Q3 | us-gaap |
Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
|
51868 | usd |
CY2023Q1 | domh |
Operating Lease Rightofuseassets
OperatingLeaseRightofuseassets
|
3619000 | usd |
CY2023Q1 | domh |
Operating Lease Current
OperatingLeaseCurrent
|
198000 | usd |
CY2023Q1 | domh |
Operating Lease Long Term1
OperatingLeaseLongTerm1
|
3363000 | usd |
CY2023Q1 | domh |
Operating Leases Liability
OperatingLeasesLiability
|
3561000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P7Y2M12D | |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.10 | pure |
CY2023Q1 | us-gaap |
Lease Cost
LeaseCost
|
100000 | usd |
CY2023Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
134 | usd |
CY2023Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
134 | usd |
CY2023Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
30 | usd |
CY2023Q1 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
164 | usd |
CY2023Q1 | domh |
Shares Cancelled
SharesCancelled
|
25000 | shares |
CY2023Q1 | domh |
Change In Fair Value Of Longterm Investment
ChangeInFairValueOfLongtermInvestment
|
usd | |
CY2023Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
34000 | usd |
CY2023Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
2796000 | usd |
CY2023Q1 | domh |
Term Of Future Minimum Payments
TermOfFutureMinimumPayments
|
P5Y | |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
|
365000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
750000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
688000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
688000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
688000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
770000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
1166000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
5115000 | usd |
CY2023Q1 | domh |
Less Present Value Discount
LessPresentValueDiscount
|
-1554000 | usd |
CY2023Q1 | domh |
Operating Lease Liabilities
OperatingLeaseLiabilities
|
3561000 | usd |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
476023 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
602445 | shares |
CY2023Q1 | domh |
Shares Cancelled
SharesCancelled
|
644499 | shares |
CY2023Q1 | us-gaap |
Common Stock Discount On Shares
CommonStockDiscountOnShares
|
644499 | usd |
CY2023Q1 | domh |
Share Repurchased
ShareRepurchased
|
236630 | shares |
CY2023Q1 | domh |
Amount Of Cost
AmountOfCost
|
0.9 | usd |
CY2023Q1 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
3.97 | |
CY2023Q1 | us-gaap |
Treasury Stock Shares Retired
TreasuryStockSharesRetired
|
644499 | shares |
CY2023Q1 | domh |
Original Cost
OriginalCost
|
3800000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
8068 | shares |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
5.64 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
8068 | shares |
CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
5.64 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
31193 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
302.97 | |
CY2022Q4 | domh |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractual
|
P7Y10M24D | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
31193 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
302.97 | |
CY2023Q1 | domh |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractual
|
P7Y8M12D | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
25311 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
372 | |
CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P7Y4M24D | |
CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
10000 | usd |
CY2022Q1 | us-gaap |
Depreciation
Depreciation
|
usd | |
CY2023Q1 | us-gaap |
Excess Capital
ExcessCapital
|
2900000 | usd |
CY2023Q1 | us-gaap |
Capital Units Net Amount
CapitalUnitsNetAmount
|
100000 | usd |
CY2023Q1 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
80000.00 | usd |
CY2022Q1 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
300000 | usd |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Dominari Holdings Inc. | |
CY2022Q4 | domh |
Clearing Broker Deposits
ClearingBrokerDeposits
|
usd | |
CY2023Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
usd | |
CY2023Q1 | domh |
Investment In Field Point Securitie
InvestmentInFieldPointSecuritie
|
usd | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
usd | |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
usd | |
CY2023Q1 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
usd | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.71 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.25 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5305513 | shares |
CY2023Q1 | domh |
Cancellation Of Common Stock
CancellationOfCommonStock
|
usd | |
CY2023Q1 | domh |
Retirement Of Treasury Stock
RetirementOfTreasuryStock
|
usd | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
usd | |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
|
usd | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
usd | |
CY2022Q1 | domh |
Distribution Of Hoth Common Stock
DistributionOfHothCommonStock
|
usd | |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
usd | |
CY2022Q1 | domh |
Increase Decrease In Prepaid Acquisition Cost
IncreaseDecreaseInPrepaidAcquisitionCost
|
usd | |
CY2022Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
usd | |
CY2022Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
usd | |
CY2023Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
usd | |
CY2023Q1 | domh |
Proceeds From Sale Of Dat Chat Common Shares
ProceedsFromSaleOfDatChatCommonShares
|
usd | |
CY2022Q1 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
usd | |
CY2023Q1 | domh |
Purchase Of Shortterm And Longterm Promissory Notes
PurchaseOfShorttermAndLongtermPromissoryNotes
|
usd | |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
usd | |
CY2022Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
usd | |
CY2023Q1 | domh |
Transfer From Longterm Investment To Marketable Securites
TransferFromLongtermInvestmentToMarketableSecurites
|
usd | |
CY2023Q1 | domh |
Promissory Convertible Note Receivable Conversion Into Common Shares
PromissoryConvertibleNoteReceivableConversionIntoCommonShares
|
usd | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
shares | |
CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
usd | |
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000012239 |